These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Thompson BJ; Jessen T; Henry LK; Field JR; Gamble KL; Gresch PJ; Carneiro AM; Horton RE; Chisnell PJ; Belova Y; McMahon DG; Daws LC; Blakely RD Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3785-90. PubMed ID: 21282638 [TBL] [Abstract][Full Text] [Related]
6. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study. Guiard BP; Mansari ME; Murphy DL; Blier P Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106 [TBL] [Abstract][Full Text] [Related]
7. Integrin αVβ3 Function Influences Citalopram Immobility Behavior in the Tail Suspension Test. Pan H; Dohn MR; Kingston R; Carneiro AMD Front Neurosci; 2019; 13():70. PubMed ID: 30787865 [TBL] [Abstract][Full Text] [Related]
8. Ontogeny of SERT Expression and Antidepressant-like Response to Escitalopram in Wild-Type and SERT Mutant Mice. Mitchell NC; Gould GG; Koek W; Daws LC J Pharmacol Exp Ther; 2016 Aug; 358(2):271-81. PubMed ID: 27288483 [TBL] [Abstract][Full Text] [Related]
9. SSRIs target prefrontal to raphe circuits during development modulating synaptic connectivity and emotional behavior. Soiza-Reilly M; Meye FJ; Olusakin J; Telley L; Petit E; Chen X; Mameli M; Jabaudon D; Sze JY; Gaspar P Mol Psychiatry; 2019 May; 24(5):726-745. PubMed ID: 30279456 [TBL] [Abstract][Full Text] [Related]
10. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. Benmansour S; Owens WA; Cecchi M; Morilak DA; Frazer A J Neurosci; 2002 Aug; 22(15):6766-72. PubMed ID: 12151556 [TBL] [Abstract][Full Text] [Related]
11. cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake. Steiner JA; Carneiro AM; Wright J; Matthies HJ; Prasad HC; Nicki CK; Dostmann WR; Buchanan CC; Corbin JD; Francis SH; Blakely RD Mol Brain; 2009 Aug; 2():26. PubMed ID: 19656393 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants. Oved K; Morag A; Pasmanik-Chor M; Rehavi M; Shomron N; Gurwitz D Transl Psychiatry; 2013 Oct; 3(10):e313. PubMed ID: 24129413 [TBL] [Abstract][Full Text] [Related]
13. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse. Nackenoff AG; Moussa-Tooks AB; McMeekin AM; Veenstra-VanderWeele J; Blakely RD Neuropsychopharmacology; 2016 Jun; 41(7):1733-41. PubMed ID: 26514584 [TBL] [Abstract][Full Text] [Related]
14. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. Carneiro AM; Cook EH; Murphy DL; Blakely RD J Clin Invest; 2008 Apr; 118(4):1544-52. PubMed ID: 18317590 [TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs). Narboux-Nême N; Pavone LM; Avallone L; Zhuang X; Gaspar P Neuropharmacology; 2008 Nov; 55(6):994-1005. PubMed ID: 18789954 [TBL] [Abstract][Full Text] [Related]
16. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360 [TBL] [Abstract][Full Text] [Related]
17. Loss of Serotonin Transporter Function Alters ADP-mediated Glycoprotein αIIbβ3 Activation through Dysregulation of the 5-HT2A Receptor. Oliver KH; Duvernay MT; Hamm HE; Carneiro AM J Biol Chem; 2016 Sep; 291(38):20210-9. PubMed ID: 27422820 [TBL] [Abstract][Full Text] [Related]
18. Synergy of oxytocin and citalopram in modulating Itgb3/Chl1 interplay: Relevance to sensitivity to SSRI therapy. Stanić D; Oved K; Israel-Elgali I; Jukić M; Batinić B; Puškaš N; Shomron N; Gurwitz D; Pešić V Psychoneuroendocrinology; 2021 Jul; 129():105234. PubMed ID: 33930757 [TBL] [Abstract][Full Text] [Related]
19. Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons. Kittler K; Lau T; Schloss P Eur J Pharmacol; 2010 Mar; 629(1-3):63-7. PubMed ID: 20006597 [TBL] [Abstract][Full Text] [Related]
20. The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes. Hagan CE; Schenk JO; Neumaier JF Synapse; 2011 Oct; 65(10):1015-23. PubMed ID: 21437992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]